FY26 Pediatric FLU
Closed Solicitation Posted
- Solicitation number
- 75D30125R73357
- Agency
- CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Atlanta, Georgia, United States
- Points of contact
-
- Chad Turner ukr9@cdc.gov
- James Sprigler zbs6@cdc.gov (404) 498-3879
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) is soliciting proposals from pediatric vaccine manufacturers to provide influenza vaccines for children ages 0-18 through the Vaccine for Children (VFC) program under solicitation number 75D30125R73357. This procurement supports the VFC program established under the Omnibus Budget Reconciliation Act of 1993, which provides vaccines to Medicaid-eligible children, uninsured children, American Indian/Alaska Native children, and children with insurance that doesn't cover vaccine costs. Offerors must be licensed manufacturers of pediatric vaccines in compliance with FDA requirements and must provide vaccines with a shelf life no earlier than June 30, 2027. The CDC will evaluate proposals based on technical compliance, pricing, and past performance factors. Proposals must be submitted electronically by August 28, 2025, at 1:00 PM EST, with an anticipated vaccine delivery timeline of Fall 2026.
This opportunity has no set-aside designation and no incumbent contractors are identified in the solicitation materials. The contract structure is an Indefinite Delivery/Indefinite Quantity (IDIQ) agreement with firm-fixed price delivery orders, featuring a combined ceiling across all awarded contracts of either 6 million doses or $710 million, whichever is reached first. Individual contracts will have a minimum order requirement of 100 doses and a maximum order quantity of 30 million doses per contract. The contract period runs from the date of award through February 28, 2027, with vaccines to be delivered to CDC centralized distribution locations in Olive Branch, Mississippi, and Clermont, Kentucky. The solicitation includes small business subcontracting goals totaling 12.17% small business participation, with additional targets for various small business categories including disadvantaged, HUBZone, women-owned, and service-disabled veteran-owned small businesses.
Notice text
The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines
for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to
prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program established pursuant to
Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the
purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The
program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve
higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the
VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American
Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which
does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural
health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are
eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these
contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at
prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional
quantities of vaccine under any resulting contract to provide immunizations for children who are not federally
vaccine-eligible children using state and local funds.
Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s.
The term "manufacturer" means any corporation, organization, or institution, whether public or private (including
Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or
distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or
distribute a vaccine
Attachments
| File | Type | Posted |
|---|---|---|
| 75D30125R73357 0001 Ped FLU.docx | DOCX document | |
| A19. 75D30125R73357 0001.pdf | ||
| A19. Attachment 03 List of Products.docx | DOCX document | |
| A19. Attachment 01 List of Vaccines.docx | DOCX document | |
| A19. Attachment 02 ADR Agreement.docx | DOCX document | |
| A19. 75D30125R73357.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity